118 related articles for article (PubMed ID: 24196083)
1. [A case of poorly differentiated adenocarcinoma of the uterine cervix treated with paclitaxel and carboplatin after positive PAX 8 immunostaining].
Maenaka T; Iwata N; Egawa-Takata T; Fukuda Y; Tsukahara C; Kashihara H; Hisamoto K; Kunishige I; Nishio Y; Tsujimoto M
Gan To Kagaku Ryoho; 2013 Oct; 40(10):1413-7. PubMed ID: 24196083
[TBL] [Abstract][Full Text] [Related]
2. Metastatic uterine cervical cancer originating in the lung: a case report.
Kai K; Takai N; Nasu K; Kira N; Ishii T; Kashima K; Narahara H
Gynecol Obstet Invest; 2009; 68(4):269-71. PubMed ID: 19776615
[TBL] [Abstract][Full Text] [Related]
3. A case of glassy cell carcinoma of the uterine cervix that responded to neoadjuvant chemotherapy with paclitaxel and carboplatin.
Takekuma M; Hirashima Y; Takahashi N; Yamamichi G; Furukawa N; Yamada Y; Takakuwa R; Ito I
Anticancer Drugs; 2006 Jul; 17(6):715-8. PubMed ID: 16917218
[TBL] [Abstract][Full Text] [Related]
4. [Neoadjuvant chemotherapy with paclitaxel and cisplantin or carboplatin for patients with locally advanced uterine cervical cancer].
Zhang R; Li B; Bai P; Li HJ; Li SM; Wu LY; Li W
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):616-20. PubMed ID: 22325224
[TBL] [Abstract][Full Text] [Related]
5. Atypical carcinoid of the uterine cervix accompanying adenocarcinoma in situ.
Ling C; Shen Y
J Clin Pathol; 2018 Nov; 71(11):1030. PubMed ID: 30154130
[TBL] [Abstract][Full Text] [Related]
6. Value of PAX 8 immunostaining in tumor diagnosis: a review and update.
Ordóñez NG
Adv Anat Pathol; 2012 May; 19(3):140-51. PubMed ID: 22498579
[TBL] [Abstract][Full Text] [Related]
7. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
[TBL] [Abstract][Full Text] [Related]
8. Multimodal treatment for glassy cell carcinoma of the uterine cervix.
Nasu K; Takai N; Narahara H
J Obstet Gynaecol Res; 2009 Jun; 35(3):584-7. PubMed ID: 19527406
[TBL] [Abstract][Full Text] [Related]
9. The activity of carboplatin and paclitaxel for recurrent cervical cancer after definitive radiotherapy.
Mabuchi S; Morishige K; Fujita M; Tsutsui T; Sakata M; Enomoto T; Kimura T
Gynecol Oncol; 2009 May; 113(2):200-4. PubMed ID: 19268342
[TBL] [Abstract][Full Text] [Related]
10. [Primary clear cell carcinoma of the cervix: report of five cases and review of the literature].
Tan YT; Zhang X; Lin ZQ; Chen Q; Wang LJ; Zhang BZ
Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):120-3. PubMed ID: 18683751
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of paclitaxel and carboplatin as a regimen for postoperative concurrent chemoradiotherapy of high risk uterine cervix cancer.
Kim K; Chie EK; Wu HG; Ha SW; Kim JS; Kim IA; Lee HP
Gynecol Oncol; 2006 Jun; 101(3):398-402. PubMed ID: 16330087
[TBL] [Abstract][Full Text] [Related]
12. Concurrent radiotherapy with paclitaxel/carboplatin chemotherapy as a definitive treatment for squamous cell carcinoma of the uterine cervix.
Lee MY; Wu HG; Kim K; Ha SW; Kim JS; Kim IA; Lee HP
Gynecol Oncol; 2007 Jan; 104(1):95-9. PubMed ID: 16996117
[TBL] [Abstract][Full Text] [Related]
13. Chemoradiation with paclitaxel and carboplatin in high-risk cervical cancer patients after radical hysterectomy: a Korean Gynecologic Oncology Group study.
Lee TS; Kang SB; Kim YT; Park BJ; Kim YM; Lee JM; Kim SM; Kim YT; Kim JH; Kim KT
Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):304-10. PubMed ID: 23642625
[TBL] [Abstract][Full Text] [Related]
14. A multi-institutional phase II trial of paclitaxel and carboplatin in the treatment of advanced or recurrent cervical cancer.
Kitagawa R; Katsumata N; Ando M; Shimizu C; Fujiwara Y; Yoshikawa H; Satoh T; Nakanishi T; Ushijima K; Kamura T
Gynecol Oncol; 2012 May; 125(2):307-11. PubMed ID: 22333993
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant combined paclitaxel and carboplatin chemotherapy for glassy cell carcinoma of the uterine cervix: report of three cases with clinicopathological analysis.
Takahashi Y; Sasaki H; Mogami H; Hamada S; Konishi I
J Obstet Gynaecol Res; 2011 Dec; 37(12):1860-3. PubMed ID: 21955049
[TBL] [Abstract][Full Text] [Related]
16. Prolonged remission of recurrent cervical carcinoma following paclitaxel and carboplatin chemotherapy with paclitaxel maintenance chemotherapy.
Micha JP; Sassoon AF; Wong H; Goldstein BH
Anticancer Drugs; 2015 Aug; 26(7):793-6. PubMed ID: 25933247
[TBL] [Abstract][Full Text] [Related]
17. Cytokeratin 7-positive/cytokeratin 20-negative cecal adenocarcinoma metastatic to the uterine cervix: a case report.
Toyoshima M; Momono Y; Makino H; Kudo T; Oka N; Sakurada J; Suzuki H; Kodama H; Yoshinaga K
World J Surg Oncol; 2016 Jan; 14(1):22. PubMed ID: 26810414
[TBL] [Abstract][Full Text] [Related]
18. Adenosquamous carcinoma of the uterine cervix--adjuvant chemotherapeutic treatment with paclitaxel and carboplatin; a case report.
Radić V; Kukura V; Ciglar S
Eur J Gynaecol Oncol; 2005; 26(4):449-50. PubMed ID: 16122201
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant chemotherapy followed by large cone resection as fertility-sparing therapy in stage IB cervical cancer.
Salihi R; Leunen K; Van Limbergen E; Moerman P; Neven P; Vergote I
Gynecol Oncol; 2015 Dec; 139(3):447-51. PubMed ID: 26050921
[TBL] [Abstract][Full Text] [Related]
20. Synchronous ovarian endometrioid adenocarcinoma and endocervical mucinous adenocarcinoma.
Huang YD; Hung YC; Yeh LS; Chiang IP; Zeng GC; Chang WC
Taiwan J Obstet Gynecol; 2006 Sep; 45(3):264-7. PubMed ID: 17175478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
